Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL25175635

COc1ccc(CN(CCOP(=O)(O)O)C(=O)CCCCc2ccc(OCCCCc3ccccc3)cc2)cc1.N

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.52
▸ MAPK1 P28482 2/20 0.51
▸ NPC1 O15118 1/20 0.51
▸ LMNA P02545 1/20 0.51
▸ ALOX15 P16050 1/20 0.51
▸ TSHR P16473 1/20 0.51
▸ HSD17B10 Q99714 1/20 0.51
▸ FFAR1 O14842 2/20 0.49
▸ S1PR1 P21453 5/20 0.48
▸ S1PR3 Q99500 4/20 0.48
▸ S1PR4 O95977 3/20 0.47
▸ S1PR5 Q9H228 3/20 0.47
▸ LPAR1 Q92633 4/20 0.46
▸ LPAR5 Q9H1C0 1/20 0.45
▸ RAF1 P04049 1/20 0.45
▸ MAP2K1 Q02750 1/20 0.45
▸ LTB4R Q15722 1/20 0.44
▸ LTB4R2 Q9NPC1 1/20 0.44
▸ LPAR2 Q9HBW0 1/20 0.44
▸ MEN1 O00255 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL25172939 0.99 ALOX5 (0.51) ALOX5MAPK1NPC1LMNAALOX15
SCHEMBL25456753 0.98 ALOX5 (0.52) ALOX5MAPK1NPC1LMNAALOX15
Ammonia Solution, Strong SCHEMBL25167618 0.95 S1PR1 (0.51) ALOX5MAPK1NPC1LMNAALOX15
SCHEMBL25456789 0.94 S1PR1 (0.51) ALOX5MAPK1NPC1LMNAALOX15
Ammonia Solution, Strong SCHEMBL25169992 0.93 S1PR1 (0.48) ALOX5MAPK1NPC1LMNAALOX15
SCHEMBL25456761 0.93 SLC2A1 (0.51) ALOX5MAPK1NPC1LMNAALOX15
SCHEMBL25456787 0.92 S1PR1 (0.49) ALOX5MAPK1NPC1LMNAALOX15
Ammonia Solution, Strong SCHEMBL25170015 0.90 ALOX5 (0.45) ALOX5MAPK1NPC1LMNAALOX15
Ammonia Solution, Strong SCHEMBL25173211 0.90 SLC2A1 (0.47) ALOX5MAPK1NPC1LMNAALOX15
SCHEMBL25456759 0.89 ALOX5 (0.46) ALOX5MAPK1NPC1LMNAALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11802135-B2 Lysophosphatidic acid derivative MITSUBISHI TANABE PHARMA CORPORATION (JP) 2023-10-31 — — US disclosed
US-20230146210-A1 NOVEL LYSOPHOSPHATIDIC ACID DERIVATIVE MITSUBISHI TANABE PHARMA CORPORATION (JP) 2023-05-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11802135-B2 Lysophosphatidic acid derivative LPAR4, LPAR2, LPAR1 ALOX5 134/4885MAPK1 2484/4885NPC1 1290/4885
US-20230146210-A1 NOVEL LYSOPHOSPHATIDIC ACID DERIVATIVE LPAR4, LPAR2, LPAR1 ALOX5 165/4885MAPK1 2490/4885NPC1 1394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback